Skip to content

Understanding How Anaesthesia Affects ECT Outcomes

Understanding How Anaesthesia Affects ECT Outcomes

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03105245
Enrollment
54
Registered
2017-04-07
Start date
2017-03-15
Completion date
2019-03-15
Last updated
2023-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

electroconvulsive therapy, anaesthesia

Brief summary

This study will examine how anaesthetic technique affects ECT outcomes. Specifically, the investigators will examine how: 1) the time interval between anaesthetic and ECT stimulus, and 2) the ventilation rate before ECT stimulus, impacts on the quality of the EEG (this is a recording of brain activity during ECT and is used to judge the quality of a seizure and to guide individual patient dosing).

Detailed description

This study aims to examine how the time interval between administration of anaesthetic agent and ECT stimulus delivery impacts upon measures of EEG quality (seizure quality).

Interventions

OTHERElectroconvulsive Therapy (ECT) time interval + Anaesthetic (Thiopentone)

The intervention in this study is the time interval between anaesthetic administration and ECT stimulus

Sponsors

Wesley Mission
CollaboratorOTHER
The University of New South Wales
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Both participants and the outcome assessor (analysing EEGs) will be blinded.

Intervention model description

Each participant will receive all four treatment conditions in randomly allocated sequence during their ECT course. That is, participants will receive either short or long anaesthetic-ECT stimulus time interval treatments, and normal or hyperventilation treatments - this results in four possible combinations, which individual participants will cycle through in random order during their ECT course (e.g. short-hyperventilation, long-normal ventilation, short-normal ventilation, long-hyperventilation).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients treated with a course of ECT

Exclusion criteria

* Use of non-standard anaesthetic agents in ECT (e.g. ketamine)

Design outcomes

Primary

MeasureTime frameDescription
EEG Seizure Quality Rating using the EEG Seizure Quality Rating Sheet utilised by MacPherson et alOutcome measures will be collected immediately after each ECT treatment from the first treatment until the end of the ECT course, an estimated total of four to six weeks for most participantsEEG quality will be rated manually for each ECT treatment undertaken by a participant until the conclusion of their ECT course. This rating will be done using the EEG Seizure Quality Rating Sheet utilised by MacPherson et al - low dose lignocaine added to propofol does not attenuate the response to electroconvulsive therapy; Journal of Affective Disorders, 2010; 126: 330-333

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026